April 28, 2025
Article
Among patients with non–muscle-invasive bladder cancer, neoadjuvant mitomycin demonstrated favorable safety.
April 15, 2025
Subcutaneous Opdivo showed comparable effectiveness, safety and tolerability to IV Opdivo in advanced clear cell renal cell carcinoma.
February 19, 2025
Updated TIDE-A study findings show that maintenance Bavencio with Inlyta treatment interruption is feasible in patients with metastatic renal cell carcinoma.
February 08, 2025
Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.
My Rare Cancer Gave Me Permission to Live
Why Relationships are Key When Caring For Patients With MPNs
Understanding the Unique Task of Treating Older Patients With Breast Cancer
I Found Strength After Surviving Multiple Myeloma and Through Recovery